GHB and driving impairment.

Author(s)
Couper, F.J. & Logan, B.K.
Year
Abstract

Gamma hydroxybutyrate (GHB) was identified in the blood of 13 subjects arrested for impaired driving. GHB concentrations ranged from 26 to 155 mg/L (mean 87 mg/L, median 95 mg/L). In eight cases, GHB was the only drug detected, and signs of impairment were consistent with those of a CNS depressant, including erratic driving (weaving, swerving, ignoring road signs), confusion, incoherent speech, unresponsiveness, lack of balance, unsteady coordination, poor performances on field sobriety tests, and varying states of wakefulness. Given the ability of GHB to induce sleep and unconsciousness, it is evident from these cases that recreational use of the drug has the potential to impair a person's driving ability. (Author/publisher)

Request publication

5 + 6 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Publication

Library number
20070945 ST [electronic version only]
Source

Journal of Forensic Sciences, Vol. 46 (2001), No. 4 (July), p. 919-923, 32 ref.

Our collection

This publication is one of our other publications, and part of our extensive collection of road safety literature, that also includes the SWOV publications.